Physician

Aditi Satti, MD

According to 2025 Medicare claims, Aditi Satti, MD (NPI: 1366698987) practices pulmonary disease in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is TEMPLE FACULTY PRACTICE PLAN, INC (NPI: 1104309889; TIN: 831002191) and primary practice location at 19140-5103.

Satti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 131 traditional Medicare patients, billed 230 HCPCS/CPT codes, and received $24,186 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 605 prescription claims across 98 beneficiaries totaling $381,962 in drug costs, led by Pirfenidone (Pirfenidone). DME data shows 286 claims. Open Payments data shows 3 records totaling $60. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $39,319 and ending at $24,186. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $429,312 and ending at $381,962. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $22,659 and ending at $14,141.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	226	608	$39,319
2016	278	1,249	$65,238
2017	300	648	$51,754
2018	385	857	$72,205
2019	308	727	$52,354
2020	278	577	$42,358
2021	222	862	$68,696
2022	184	363	$42,638
2023	151	281	$27,055
2024	131	230	$24,186

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	162	974	$429,312
2016	152	811	$399,344
2017	152	882	$637,471
2018	146	976	$786,602
2019	128	802	$575,826
2020	106	596	$374,100
2021	95	603	$665,752
2022	94	561	$640,425
2023	86	551	$481,469
2024	98	605	$381,962

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	181	$24,090
2016	N/R	175	$15,160
2017	47	326	$22,420
2018	49	456	$25,531
2019	52	552	$50,973
2020	46	443	$37,486
2021	11	388	$39,020
2022	52	446	$32,885
2023	14	315	$13,979
2024	N/R	286	$13,255

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	30	57	$167
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	50	70	$84
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	33	59	$64
99238	Hospital discharge day management, 30 minutes or less	11	11	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pirfenidone	Pirfenidone	20	584	$72,581
Fasenra	Benralizumab	12	672	$65,536
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	62	2,640	$54,932
Spiriva Handihaler	Tiotropium Bromide	11	990	$16,230
Spiriva Respimat	Tiotropium Bromide	27	810	$13,864

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	90	$6,184
E1392	Portable oxygen concentrator, rental	Y	N/R	50	$1,597
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	N/R	20	$1,403
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	22	$1,316
A7030	Full face mask used with positive airway pressure device, each	N	N/R	11	$879

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$60	Inspire Medical Systems, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aditi Satti, MD?

Tedicare shows public-source Medicare data for Aditi Satti, MD (NPI 1366698987), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aditi Satti, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aditi Satti, MD?

Aditi Satti, MD is linked to TEMPLE FACULTY PRACTICE PLAN, INC (billing NPI 1104309889) in the available physician profile data.

Does Aditi Satti, MD have Open Payments data?

Aditi Satti, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.